Minerva Neurosciences, Inc (NERV) Financial Statements (2024 and earlier)

Company Profile

Business Address 1601 TRAPELO ROAD
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36,09460,75525,35745,85487,997128,161
Cash and cash equivalents36,09460,75525,35721,41350,23526,052
Short-term investments    24,44237,762102,109
Restricted cash and investments10010010010010080
Prepaid expense8481,3461,9831,1821,9211,299
Other undisclosed current assets 3,117     
Total current assets:40,15962,20127,44047,13790,018129,540
Noncurrent Assets
Operating lease, right-of-use asset   102262
Property, plant and equipment16  163351
Long-term investments and receivables      5,023
Long-term investments      5,023
Intangible assets, net (including goodwill)14,86914,86930,06930,06949,06949,069
Goodwill14,86914,86914,86914,86914,86914,869
Intangible assets, net (excluding goodwill)   15,20015,20034,20034,200
Other noncurrent assets   15151515
Other undisclosed noncurrent assets4351    
Total noncurrent assets:14,92814,92030,18630,36249,11854,158
TOTAL ASSETS:55,08777,12257,62677,499139,136183,699
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0981,9161,1372,6312,2551,713
Interest and dividends payable    21
Employee-related liabilities    6
Accounts payable9701,8539962,3171,8001,436
Accrued liabilities12863141314456251
Debt    173 3,963
Other undisclosed current liabilities2799032,0243,8251,3541,162
Total current liabilities:1,3782,8193,1606,6293,6096,838
Noncurrent Liabilities
Long-term debt and lease obligation:    111  
Liabilities, other than long-term debt   1,80342,97941,20545,263
Deferred revenue and credits41,176
Deferred revenue    41,176
Contract with customer, liability41,176
Deferred tax liabilities, net 4,057
Deferred income tax liabilities   1,8031,803
Other liabilities     2930
Operating lease, liability    111
Other undisclosed noncurrent liabilities73,73466,327  4,057 
Total noncurrent liabilities:73,73466,3271,80343,09045,26245,263
Total liabilities:75,11169,1464,96449,71948,87152,101
Equity
Equity, attributable to parent(20,024)7,97652,66327,78090,265131,597
Common stock144444
Additional paid in capital346,785342,673337,454314,512304,814295,975
Accumulated deficit(366,810)(334,701)(284,795)(286,736)(214,553)(164,381)
Total equity:(20,024)7,97652,66327,78090,265131,597
TOTAL LIABILITIES AND EQUITY:55,08777,12257,62677,499139,136183,699

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues   41,176   
Gross profit:   41,176   
Operating expenses(25,231)(45,366)(39,329)(75,865)(51,730)(41,170)
Operating income (loss):(25,231)(45,366)1,847(75,865)(51,730)(41,170)
Nonoperating income (expense)529(16)941,4271,669885
Investment income, nonoperating557171611,4561,674942
Loss, foreign currency transaction, before tax(28)(33)(67)(29)(5)(57)
Income (loss) from continuing operations before equity method investments, income taxes:(24,702)(45,382)1,941(74,438)(50,061)(40,285)
Other undisclosed loss from continuing operations before income taxes(7,407)(6,327)  (110)(614)
Income (loss) from continuing operations before income taxes:(32,109)(51,709)1,941(74,438)(50,171)(40,899)
Income tax benefit  1,803 2,254 9,376
Income (loss) from continuing operations:(32,109)(49,906)1,941(72,183)(50,171)(31,523)
Income (loss) before gain (loss) on sale of properties:(49,906)1,941(72,183)(50,171)(31,523)
Other undisclosed net income      
Net income (loss):(32,109)(49,906)1,941(72,183)(50,171)(31,523)
Other undisclosed net loss attributable to parent      
Net income (loss) available to common stockholders, diluted:(32,109)(49,906)1,941(72,183)(50,171)(31,523)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(32,109)(49,906)1,941(72,183)(50,171)(31,523)
Comprehensive income (loss), net of tax, attributable to parent:(32,109)(49,906)1,941(72,183)(50,171)(31,523)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: